All Pharma News
Otsuka and Lundbeck’s schizophrenia treatment gains EC approval

Otsuka and Lundbeck’s schizophrenia treatment gains EC approval
PHARMACEUTICAL TECHNOLOGY
28 Mar 2024
Share Share
Otsuka and Lundbeck Present New Data Analyses on the Efficacy of REXULTI

Otsuka and Lundbeck Present New Data Analyses on the Efficacy of REXULTI
BUSINESSWIRE
18 Mar 2024
Share Share
Otsuka and Sumitomo Revise License Agreement

Otsuka and Sumitomo Revise License Agreement
PRESS RELEASE
15 Mar 2024
Share Share
Otsuka Submits New Drug Application in Japan for Voclosporin

Otsuka Submits New Drug Application in Japan for Voclosporin
PRESS RELEASE
10 Nov 2023
Share Share
Selected as METI`s

Selected as METI`s "Model Project for the Promotion of PHR Services" Launch of a Healthcare Service
PRESS RELEASE
08 Nov 2023
Share Share
MIREVO® Obtains Regulatory Approval, a First in Japan

MIREVO® Obtains Regulatory Approval, a First in Japan
PRESS RELEASE
08 Nov 2023
Share Share
Otsuka Pharmaceutical Granted Silver Certification in PRIDE Index 2023

Otsuka Pharmaceutical Granted Silver Certification in PRIDE Index 2023
PRESS RELEASE
07 Nov 2023
Share Share
New England Journal of Medicine Publishes Complete Results of Positive Phase 2 Trial of Sibeprenlimab

New England Journal of Medicine Publishes Complete Results of Positive Phase 2 Trial of Sibeprenlimab
PRESS RELEASE
06 Nov 2023
Share Share
Otsuka Announces Personnel Changes

Otsuka Announces Personnel Changes
PRESS RELEASE
06 Nov 2023
Share Share
Lundbeck, Otsuka dial down the drama for Rexulti agitation ad

Lundbeck, Otsuka dial down the drama for Rexulti agitation ad
Nick Paul Taylor FIERCE PHARMA
13 Oct 2023
Share Share